Is Zydus Wellness a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Zydus Wellness Ltd is a good quality company .

Is Zydus Wellness undervalued or overvalued?

The key valuation ratios of Zydus Wellness Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone .

What is Zydus Wellness share price return in the past 10 years?

Zydus Wellness Ltd share price has appreciated 12.1% annually (CAGR) over the past ten years.

Is Zydus Wellness a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Zydus Wellness Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

Zydus Wellness Ltd - Stock Valuation and Financial Performance

Name: Zydus Wellness
Brand: Zydus Wellness

BSE: 531335 | NSE: ZYDUSWELL | Consumer Food | Small Cap

Place order

Zydus Wellness Share Price

₹2,079.65 8.70 0.42%
as on 20-Sep'24 16:01

10 Year X-Ray of Zydus Wellness:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	32.7%	26.4%	23.5%	23.3%	7.1%	5.3%	3.9%	6.4%	5.8%	5.1%	-
Value Creation Index ⓘ	1.3	0.9	0.7	0.7	-0.5	-0.6	-0.7	-0.5	-0.6	-0.6	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	431	397	431	513	843	1,767	1,867	2,009	2,255	2,328	2,455
Sales YoY Gr.	-	-7.9%	8.5%	19.1%	64.4%	109.6%	5.7%	7.6%	12.2%	3.2%	-
Adj EPS ⓘ	27.8	26.4	27.7	33.5	28.4	29.3	33.2	48.6	49.8	43.3	47.8
YoY Gr.	-	-5%	5.1%	20.8%	-15.3%	3.4%	13.2%	46.6%	2.3%	-13.1%	-
BVPS (₹) ⓘ	103.9	122.5	142.6	176.9	587.3	600.2	717.9	761.3	805.4	842.4	865.2
Adj Net Profit ⓘ	108	103	108	131	164	169	211	310	317	275	304
Cash Flow from Ops. ⓘ	69.2	89.9	77	69.1	149	259	287	237	91.7	246	-
Debt/CF from Ops. ⓘ	0	0	0.3	0.4	10.5	5.9	1.9	1.6	3.2	1.3	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	20.6%	22.5%	7.6%	3.2%
Adj EPS ⓘ	5.1%	8.8%	9.2%	-13.1%
BVPSⓘ	26.2%	7.5%	5.5%	4.6%
Share Price	12.1%	4.7%	-4.8%	30%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	29.7	23.3	20.9	21	8	4.9	5.3	6.6	6.4	5.3	5.6
Op. Profit Mgn % ⓘ	23.2	23	23.1	24.4	21.9	18.2	18.5	17.1	15	13.2	14.1
Net Profit Mgn % ⓘ	25.7	26.5	25.7	26	19.7	9.6	11.3	15.4	14	11.8	12.4
Debt to Equity ⓘ	0	0	0	0	0.5	0.4	0.1	0.1	0.1	0.1	-
Working Cap Days ⓘ	59	73	55	50	142	110	110	114	118	128	81
Cash Conv. Cycle ⓘ	-35	-50	-51	-45	-67	-45	-34	-9	24	39	28

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to 5.60%

Sales growth has been subdued in last 3 years 7.64%

Net Profit has been subdued in last 3 years 9.23%

Sales growth is not so good in last 4 quarters at 7.28%

Latest Financials - Zydus Wellness Ltd.

	Standalone	Consolidated
TTM EPS (₹)	5	47.8
TTM Sales (₹ Cr.)	212	2,455
BVPS (₹.) ⓘ	635.2	865.2
Reserves (₹ Cr.) ⓘ	3,979	5,442
P/BV ⓘ	3.28	2.41
PE ⓘ	417.99	43.56

From the Market
52 Week Low / High (₹)	1441.75 / 2484.00
All Time Low / High (₹)	2.05 / 2484.00
Market Cap (₹ Cr.)	13,250
Equity (₹ Cr.)	63.6
Face Value (₹)	10
Industry PE ⓘ	76.2

Management X-Ray of Zydus Wellness:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Zydus Wellness

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Zydus Wellness

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	431	397	431	513	843	1,767	1,867	2,009	2,255	2,328
Operating Expenses ⓘ	331	305	332	387	658	1,446	1,522	1,667	1,918	2,020
Manufacturing Costs	55	54	56	66	108	103	102	78	98	104
Material Costs	83	81	92	113	216	779	845	980	1,146	1,138
Employee Cost	34	39	45	54	82	152	159	159	162	186
Other Costs ⓘ	158	131	138	154	252	411	416	450	512	591
Operating Profit ⓘ	100	91	99	125	185	321	344	342	337	308
Operating Profit Margin (%)	23.2%	23.0%	23.0%	24.4%	21.9%	18.2%	18.4%	17.0%	15.0%	13.2%
Other Income ⓘ	28	32	33	35	39	11	9	13	5	14
Interest ⓘ	0	0	1	2	30	140	84	26	16	24
Depreciation ⓘ	8	7	7	9	13	26	25	24	25	24
Exceptional Items ⓘ	0	0	0	0	-10	-44	-132	0	-10	-14
Profit Before Tax ⓘ	120	117	124	150	171	121	112	306	291	260
Tax ⓘ	9	12	13	13	-1	-20	-7	-3	-20	-7
Profit After Tax	111	105	111	137	171	142	119	309	310	267
PAT Margin (%)	25.8%	26.5%	25.8%	26.6%	20.3%	8.0%	6.4%	15.4%	13.8%	11.5%
Adjusted EPS (₹)	27.9	26.4	27.9	34.3	29.3	24.6	18.7	48.5	48.8	42.0
Dividend Payout Ratio (%)	22%	25%	23%	23%	17%	20%	27%	10%	10%	12%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	406	479	557	691	3,386	3,461	4,568	4,844	5,123	5,358
Share Capital ⓘ	39	39	39	39	58	58	64	64	64	64
Reserves ⓘ	367	439	518	652	3,329	3,403	4,504	4,780	5,059	5,294
Minority Interest	7	9	11	13	0	0	0	0	0	0
Debt	0	0	25	25	1,569	1,519	550	132	230	324
Long Term Debt	0	0	0	0	1,500	1,500	313	63	0	0
Short Term Debt	0	0	25	25	69	19	237	69	230	324
Trade Payables	50	63	67	79	392	504	439	364	313	363
Others Liabilities ⓘ	45	17	-33	-53	8	-15	-16	311	18	-52
Total Liabilities ⓘ	508	568	626	755	5,356	5,469	5,540	5,651	5,684	5,992
Fixed Assets
Gross Block	113	117	144	154	4,712	4,844	4,858	4,919	4,961	4,934
Accumulated Depreciation	28	35	42	51	144	170	190	209	228	226
Net Fixed Assetsⓘ	84	82	103	104	4,567	4,674	4,667	4,710	4,732	4,708
CWIP ⓘ	0	0	0	0	10	4	4	12	13	10
Investmentsⓘ	0	94	30	148	46	110	0	27	70	78
Inventories	26	24	32	35	233	292	365	362	458	468
Trade Receivables	1	3	4	9	96	118	94	142	208	283
Cash Equivalents	339	305	440	414	164	82	253	170	38	240
Others Assetsⓘ	57	60	17	46	238	188	157	228	165	207
Total Assets ⓘ	508	568	626	755	5,356	5,469	5,540	5,651	5,684	5,992

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	69	90	77	69	149	259	287	237	92	246
PBT ⓘ	120	117	124	150	171	121	112	306	291	260
Adjustment ⓘ	-19	-25	-23	-21	-8	163	240	41	42	33
Changes in Working Capital ⓘ	-21	12	-15	-48	49	-23	-66	-106	-240	-44
Tax Paid ⓘ	-11	-14	-9	-12	-63	-2	0	-4	-1	-3
Cash Flow From Investing Activity ⓘ	29	-28	-72	-59	-4,162	-17	-10	-86	-85	-19
Capex	3	-4	-31	-8	-17	-25	-17	-75	-44	-26
Net Investments	0	-55	-73	-82	460	2	0	-21	-41	-5
Others ⓘ	27	31	31	31	-4,604	5	7	9	1	12
Cash Flow From Financing Activityⓘ	-27	-58	-6	-2	4,052	-260	-216	-234	-139	-26
Net Proceeds from Shares ⓘ	0	0	0	0	2,575	0	987	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	1,500	0	-1,320	-188	-250	-63
Interest Paid ⓘ	0	0	-1	0	-30	-140	-101	-32	-16	-24
Dividend Paid ⓘ	-23	-48	-25	-2	-31	-58	0	-32	-32	-32
Others ⓘ	-4	-10	20	0	38	-62	218	18	159	92
Net Cash Flow ⓘ	71	4	-1	8	39	-18	60	-83	-132	201

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	30.39	23.79	21.49	21.87	8.4	4.14	2.96	6.56	6.23	5.09
ROCE (%)	32.74	26.44	23.48	23.33	7.08	5.26	3.88	6.41	5.77	5.12
Asset Turnover Ratio	0.97	0.79	0.77	0.75	0.28	0.36	0.37	0.38	0.43	0.43
PAT to CFO Conversion(x)	0.62	0.86	0.69	0.5	0.87	1.82	2.41	0.77	0.3	0.92
Working Capital Days
Receivable Days	2	2	3	4	23	20	19	20	26	36
Inventory Days	22	21	22	23	58	50	60	62	62	68
Payable Days	219	256	257	235	397	210	204	149	108	108

Zydus Wellness Ltd Stock News

Zydus Wellness Ltd FAQs

What is the share price of Zydus Wellness?

Company share prices are keep on changing according to the market conditions. The closing price of Zydus Wellness on 20-Sep-2024 16:01 is ₹2,079.7.

What is the market cap of Zydus Wellness?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 20-Sep-2024 16:01 the market cap of Zydus Wellness stood at ₹13,250.4.

What is the P/E ratio of Zydus Wellness?

The latest P/E ratio of Zydus Wellness as of 20-Sep-2024 16:01 is 418.0.

What is the P/B ratio of Zydus Wellness?

The latest P/B ratio of Zydus Wellness as of 20-Sep-2024 16:01 is 3.28.

What is the 52-week high and low of Zydus Wellness?

The 52-week high of Zydus Wellness is ₹2,484 and the 52-week low is ₹1,441.8.

What is the TTM revenue of Zydus Wellness?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Zydus Wellness is ₹212.4 ( Cr.) .

About Zydus Wellness Ltd

Zydus Wellness Ltd. is established in 1988. The company is a leading consumer wellness company with an Indian heritage and a global footprint. It believes, a healthy lifestyle is not just about being active but also about feeling good from within. So, it approaches health and wellness in a holistic manner. It nourishes, nurture and energize millions of lives by offering a variety of innovative, industry-leading products. With several years of operational excellence, it has seven leading brands in its portfolio, namely Complan, Sugar Free, Glucon-D, Everyuth, Nycil, Sugarlite and Nutralite.

Headquartered in Ahmedabad and Mumbai, it has many manufacturing facilities across several locations - Aligarh, Sitarganj. Ahmedabad and Sikkim. It also has 8 co-packing facilities in India, Oman and Newzealand. Its core pillars -manufacturing integrity, supply chain efficiency, and product innovation, form the basis of the legacy it has built over the last few decades. Currently the Zydus Wellness business spans over several countries and many continents. It combines the best of healthcare, nutrition and cosmeceutical products to provide quality wellness products. It helps people pursue integrated well-being through its widening range of products.

Business area of the company

The company is an integrated consumer company. The Company is engaged in the development, production, marketing and distribution of health and wellness products.

Product of the Company

The Company has a wide range of health and wellness products. The Company’s product portfolio includes popular brands with functional benefits like Glucon D, Complan, Sugar Free, Nycil, Everyuth, Nutralite and Sugarlite.

Awards

2017-18

Its Sikkim plant received the Gold Award at the National Award for Manufacturing Competitiveness (NAMC), conducted by International Research Institute of Manufacturing.
Its flagship brand Sugar Free won the ‘Best Integration of Brand and Movie’ award at the Prime Time Awards 2017 for its association with the Bollywood film, ‘Chef’.
National Gold Award for Manufacturing Competitiveness.

2018-19

The Sikkim plant was presented with the Gold award by the International Research Institute of Manufacturing.
The Ahmedabad plant (Nutralite) was presented the Silver award by the International Research Institute of Manufacturing at the National Award for Manufacturing Competitiveness 2018.
The Sikkim plant was presented the Silver award at the India Manufacturing Excellence Award held by Frost and Sullivan.
The Company was presented the Best SLIM Lead Award for manufacturing facilities in an exercise organised by the Zydus group.
Won the India Packaging Award for Sugar Free Green Veda pack for Excellence in Packaging Design.
Won three Inflection Awards for the Best Procurement Team of the Year, 2018.
Sugar Free won the Gold Award at Abby Awards (Publishers) for the Company’s West Bengal initiative with ABP.

2019-20

Most Trusted Brands 2020

Milestones

1988: Launched Sugar Free with Aspartame.
1991: Launched the Everyuth skincare range.
2005: Introduced Sugar Free Natura with Sucralose.
2006: Acquired Carnation NutraAnalogue Foods Ltd.
2009: Restructured the consumer business of Cadila Healthcare Ltd., renamed Zydus Wellness Ltd.
2011: Inaugurated the manufacturing plant in Sikkim.
2017: Commissioned the new production facility in Sikkim.
2017: Launched Sugar Free Green with Stevia.
2018: Introduced Nutralite Mayonnaise in three appealing flavours: vegetable, cheese garlic and achari.
2019: Acquired Heinz India Pvt. Ltd.